Phase III design for a trial of single-dose fosaprepitant (FA) in preventing chemotherapy-induced nausea and vomiting (CINV) associated with moderately emetogenic chemotherapy (MEC)

Abstract only

Saved in:

Bibliographic Details
Published in:	Journal of clinical oncology Vol. 32; no. 15_suppl; p. TPS9664
Main Authors:	Noga, Stephen Joseph, Weinstein, Cindy, Camacho, Elber S, Khanani, Saleem A, Beckford-Brathwaite, Elizabeth, Vallejos, Waldimir, McGowan, Kelly, Tamburri, Grace, Force, Joanne, Taylor, Arlene
Format:	Journal Article
Language:	English
Published:	20-05-2014
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!